Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Elanco Animal Health sees FY2024 EPS of $0.89-$0.95, versus the consensus of $0.91.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.